Table 2.
Comparison between the different studied groups according to different parameters.
| Cancer (n = 30) | Benign (n = 30) | Control (n = 30) | p |
Post hoc test (LSD or Dunn's) |
|||
|---|---|---|---|---|---|---|---|
| Cancer vs. benign | Cancer vs. control | Benign vs. control | |||||
| Hb% (gm/dl) | 9 ± 1.5 | 11.8 ± 0.7 | 11.9 ± 0.6 | < 0.001* | < 0.001* | < 0.001* | 0.739 |
| CEA mg/dl | 21 (9–43) | 8 (5–12) | 8 (5–12) | < 0.001* | < 0.001* | < 0.001* | 0.860 |
| CA19–9 U/ml | 28.5 (10–51) | 12 (9–15) | 12 (9–15) | < 0.001* | < 0.001* | < 0.001* | 0.709 |
| Gene expression of micro-RNA 34a | 1.2 (0.2–6.7) | 16.1 (8.9–19.7) | 16.7(11.8–20.1) | < 0.001* | < 0.001* | < 0.001* | 0.530 |
| P53 gene expression | 1.4 (0.1–6.6) | 10.3 (8.6–12.4) | 10.8 (8.6–15.7) | < 0.001* | < 0.001* | < 0.001* | 0.137 |
Normally quantitative data was expressed in mean ± SD and was compared using F test (ANOVA) abnormally distributed data was expressed in median (Min.–Max.) and was compared using Kruskal Wallis test.
*
Statistically significant at p ≤ 0.05.